048410.KQ

Hyundai Bioscience Co., Ltd. [048410.KQ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

048410.KQ Stock Summary

Top 10 Correlated ETFs

048410.KQ

Top 10 Correlated Stocks

048410.KQ

In the News

048410.KQ Financial details

Company Rating
-
Market Cap
791.59B
Income
-14.5B
Revenue
9.48B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
63
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-52.97
Forward P/E
-
PEG
57.28
P/S
92.98
P/B
17.43
P/C
-
P/FCF
-85.33
Quick Ratio
2.17
Current Ratio
2.59
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-364.4
EPS next Y
-
EPS next Q
-
EPS this Y
-9.21%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-20.62%
Revenue Q/Q
-42.25%
EPS Q/Q
308.55%
-
-
-
-
SMA20
5.55%
SMA50
-3.65%
SMA100
-16.13%
Inst Own
-
Inst Trans
-
ROA
-29%
ROE
-31%
ROC
-0.32%
Gross Margin
53%
Oper. Margin
-170%
Profit Margin
-175%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
17600.0-41200.0
52W High
-87.95%
52W Low
-71.79%
RSI
39.8
Rel Volume
0.81
Avg Volume
466.01K
Volume
375.89K
Perf Week
-5.61%
Perf Month
-0.6%
Perf Quarter
9.6%
Perf Half Y
12.46%
-
-
-
-
Beta
1.171
-
-
Volatility
109.24%, 352.52%
Prev Close
-2.07%
Price
4965
Change
-0.7%

Something similar

Top by Market Cap
NVDA
ABEA.DE
GOOG
LLY.SW
BRK-B
Top Correlated ETFs
104530.KS
091220.KS
139270.KS
279530.KS
284980.KS
Top Correlated Stocks
015750.KQ
049950.KQ
028670.KS
1313.TW
100120.KQ
Similar Market Cap
MAXHEALTH.NS
003540.KS
BAJAJHLDNG.NS
6302.T
8954.T

Company Profile

Healthcare Medical - Pharmaceuticals

Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body. The company provides Vitabrid C12, a new-conceptual vitamin C product that delivers active vitamin C into the skin. It also develops organic-inorganic hybrid technology, a drug delivery system technology that allows the selective and effective delivery of active substances on the target area in combination with bio-friendly minerals, as well as in anticancer drug carrier technology. The company was founded in 2000 and is based in Seoul, South Korea.